What Challenges Exist in Nanotechnology-Based Drug Delivery?
Despite the potential, several challenges need to be addressed:
Toxicity: The safety of nanomaterials is a significant concern. Long-term studies are needed to understand their toxicity and biocompatibility. Scalability: Manufacturing nanoparticles consistently on a large scale can be challenging and cost-prohibitive. Regulatory Hurdles: Regulatory agencies require extensive data on the safety and efficacy of nanomedicines, which can delay their approval. Stability: Ensuring the physical and chemical stability of nanoparticle formulations during storage and transportation is crucial.
